India to Bangladesh: Vaccine Export Trade Route

The India to Bangladesh Vaccine corridor is one of India's established pharmaceutical export routes, with 270 shipments documented worth a combined $78.1M USD. The route is dominated by BIOLOGICAL E. LIMITED, which alone accounts for roughly 49% of all export value, reflecting the consolidated nature of India's vaccine manufacturing sector.

Across 20 active suppliers, the average shipment value stands at $289.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with vaccine's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 22.2%, placing it at rank #20 among India's top vaccine export destinations globally.

On the import side, key buyers of Indian vaccine in Bangladesh include D.G. CENTRAL MEDICAL STORES DEPT, D G CENTRAL MEDICAL STORES DEPT, D.G. CENTRAL MEDICAL STORES DEPT. and 42 others. D.G. CENTRAL MEDICAL STORES DEPT is the single largest importer with 39 shipments valued at $33.0M USD.

India's vaccine exports to Bangladesh are driven primarily by a handful of large-scale manufacturers. BIOLOGICAL E. LIMITED with 70 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 20 active exporters signals a competitive but concentrated market — buyers in Bangladesh benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BIOLOGICAL E. LIMITED, PANACEA BIOTEC LIMITED, BIOLOGICAL E. LIMITED — together account for 76% of total trade value on this route. The average shipment value of $289.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as mr vaccine measles and rubella vaccine c and mr vaccine measles and rubella vaccine combined vial of 5 doses with diluent. with vaccine vial monitor (vvm), suggesting that buyers in Bangladesh tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, D.G. CENTRAL MEDICAL STORES DEPT is the largest importer with 39 shipments worth $33.0M USD — representing 42% of all vaccine imports from India on this route. A total of 45 buyers are active on this corridor.